ChemoCentryx
CCXI
#3611
Rank
HK$29.21 B
Marketcap
HK$406.17
Share price
0.00%
Change (1 day)
34.33%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.77. In 2021 the company made an earnings per share (EPS) of -HK$14.77 a decrease over its 2020 EPS that were of -HK$6.33.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.780.07%
2021-HK$14.77133.33%
2020-HK$6.33-16.49%
2019-HK$7.5827.63%
2018-HK$5.94-305.41%
2017HK$2.89-142.53%
2016-HK$6.80-19.44%
2015-HK$8.44-0%
2014-HK$8.4413.68%
2013-HK$7.42-16.67%
2012-HK$8.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.01-689.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.62-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.69-226.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$111.95-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.86-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.08-486.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.20-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.44-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.69-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel